Published in Scand J Rheumatol on January 01, 1979
Immunity in tuberculosis. Bull World Health Organ (1982) 1.04
Vaccinations in juvenile chronic inflammatory diseases: an update. Nat Rev Rheumatol (2013) 0.81
[Immunity in tuberculosis]. Bull World Health Organ (1982) 0.75
Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest (1973) 2.84
Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol (1972) 2.70
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
Characterization of IgG complexes in eluates from rheumatoid tissue. Clin Exp Immunol (1971) 1.99
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97
Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1972) 1.79
Neonatal cholestasis in alpha-1-antitrypsin deficient children. Clinical, genetic, histological and immunohistochemical findings. Acta Paediatr Scand (1972) 1.77
Rheumatoid factor in synovial effusions: local production and consumption. Clin Exp Immunol (1967) 1.69
Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice. Ann Rheum Dis (1980) 1.68
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
Measures to prevent TRALI. Vox Sang (2007) 1.58
HLA-D associated alloantisera react with molecules similar to Ia antigens. Proc Natl Acad Sci U S A (1977) 1.52
Complement-fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol (1972) 1.47
The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand J Immunol (1995) 1.47
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol (1979) 1.36
Self-associating IgG rheumatoid factor represents a major response of plasma cells in rheumatoid inflammatory tissue. Ann N Y Acad Sci (1975) 1.34
Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same? Proc R Soc Med (1977) 1.33
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain (1988) 1.25
Rheumatoid synovial lymphocytes lack concanavalin-A-activated suppressor cell activity. Scand J Immunol (1979) 1.25
The role of the laboratory in rheumatology. Rheumatoid factors. Clin Rheum Dis (1983) 1.25
Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate). Scand J Rheumatol Suppl (1979) 1.24
Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. Postgrad Med J (1974) 1.24
Detection of genetic markers of human immunoglobulins by immunofluorescence technique. Ann N Y Acad Sci (1971) 1.22
A peroxiredoxin antioxidant is encoded by a dormancy-related gene, Per1, expressed during late development in the aleurone and embryo of barley grains. Plant Mol Biol (1996) 1.21
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer (2013) 1.20
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum (1986) 1.20
Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis (1983) 1.19
In situ characterization of mononuclear cells in rheumatoid tissues, using monoclonal antibodies. No reduction of T8-positive cells or augmentation in T4-positive cells. Scand J Immunol (1982) 1.17
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17
Capillary column gas chromatography--mass spectrometry in studies on rheumatoid arthritis. J Chromatogr (1978) 1.16
Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J Biol Chem (1998) 1.11
Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints. Clin Exp Immunol (1980) 1.06
The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story. Transfus Apher Sci (2003) 1.06
Experimentally produced antibodies to the pepsin site of IgG due to untreated autologous IgG in immune complexes. Clin Exp Immunol (1970) 1.05
Antiserum inhibition of the mixed lymphocyte culture (MLC) interaction. Inhibitory effect of antibodies reactive with HLA-D-associated determinants. Cell Immunol (1977) 1.05
Relationship between IgG complexes and anti-IgG antibodies in rheumatoid arthritis. Acta Rheumatol Scand (1970) 1.05
Individual antigenic specificity of human macroglobulins: Localization of antigenic determinants and their use to demonstrate formation of hybrid molecules after reduction and reassociation. J Exp Med (1969) 1.04
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant (2000) 1.03
D-penicillamine-induced increase in intracellular glutathione correlating to clinical response in rheumatoid arthritis. J Rheumatol Suppl (1981) 1.02
Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis. Ann Rheum Dis (1982) 1.02
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
Diagnostic criteria in spondylarthritis ankylopoietica. Acta Rheumatol Scand (1968) 1.01
Further evidence of a third HL-A locus. Tissue Antigens (1973) 1.00
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood (2000) 1.00
Quantitation of cells secreting rheumatoid factor of IgG, IgA, and IgM class after elution from rheumatoid synovial tissue. Arthritis Rheum (1982) 0.99
Beta-2-microglobulin is part of the HL-A molecule in the lymphocyte membrane. Nature (1974) 0.98
Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors. Immunology (1972) 0.97
Humoral immunity in juvenille rheumatoid arthritis. Ann Rheum Dis (1974) 0.97
Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation (1999) 0.97
A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol (1989) 0.96
The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol (1991) 0.96
A study of complement fixation by rheumatoid factor using a haemolytic assay system. Clin Exp Immunol (1977) 0.96
Serologic recognition of HLA-D-associated determinants. Transplant Proc (1977) 0.96
Evidence for immune complexes containing antibody to the pepsin site of IgG in rheumatoid synovial fluids. Clin Exp Immunol (1971) 0.95
Specific binding of immunoconglutinin in tissues and synovial fluids from patients with rheumatoid arthritis. Clin Exp Immunol (1971) 0.95
Recent onset arthritis in the elderly: a 5 year longitudinal observational study. J Rheumatol (2000) 0.95
Trace elements in serum and urine of patients with rheumatoid arthritis. Scand J Rheumatol (1978) 0.95
Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints. Bone Marrow Transplant (2002) 0.94
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology (1996) 0.94
Increased intracellular glutathione during penicillamine treatment for rheumatoid arthritis. Lancet (1979) 0.94
Antibody-producing cells in bone marrow and other lymphoid tissues during the primary immune response in mice. Int Arch Allergy Appl Immunol (1971) 0.94
Immunofluorescence studies for immunoglobulins and complement C3 in synovial joint membranes in psoriatic arthritis. Clin Exp Immunol (1977) 0.93
Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis. Immunology (1974) 0.92
Strong association between an HLA-Dw3 associated B cell alloantigen and dermatitis herpetiformis. Tissue Antigens (1977) 0.92
C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model. Immunopharmacology (1999) 0.92
An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum (1987) 0.91
T-cell immunoregulatory functions in rheumatoid arthritis patients. Scand J Immunol (1983) 0.91
MLC-activating HLA-D determinants: identification, tissue distribution, and significance. Transplant Proc (1977) 0.91
Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med (1996) 0.91
Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang (2006) 0.90
Presence and origin of human IgG subclass proteins in newborns. Vox Sang (1973) 0.90
Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies. Scand J Immunol (1982) 0.89
Beta-2-microglobulin. Part of the HL-A molecule in the cell membrane. Tissue Antigens (1974) 0.89
Identification of antihistone antibodies in subsets of juvenile chronic arthritis. Ann Rheum Dis (1989) 0.89
Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand J Immunol (1993) 0.89
Indomethacin in ankylosing spondylitis. Acta Rheumatol Scand (1965) 0.89
Anti-IgG and antinuclear antibodies in juvenile rheumatoid arthritis. Scand J Rheumatol (1972) 0.88
Anti-gamma globulins and chronic infection: comparative studies of the immune response to various bacteria and gamma globulin preparations. Infect Immun (1972) 0.88
C-reactive protein and delayed hypersensitivity in juvenile rheumatoid arthritis. Scand J Rheumatol (1978) 0.87
Serological identification of five HLA-D associated (Ia-like) determinants. Tissue Antigens (1977) 0.87
The distribution of clinical findings in Bechterew's syndrome (ankylosing spondylitis) suggests distinct genetic subgroups. Clin Genet (1982) 0.87
Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor Compstatin. Transplant Proc (1999) 0.87
Quantitation of cells secreting immunoglobulins after elution from rheumatoid synovial tissue. Scand J Immunol (1982) 0.87
Vascular and renal distribution of HLA--DR-like antigens. Tissue Antigens (1981) 0.86
Dysplasia epiphysealis hemimelica. An unusual case combined with juvenile rheumatoid arthritis. Acta Rheumatol Scand (1967) 0.86
Studies on cold insoluble globulin. I Concentrations in citrated plasma in rheumatic disorders. Ann Rheum Dis (1978) 0.86
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol Suppl (1989) 0.86
Detection of Fc-receptor-bearing human lymphocytes. The majority of Tmu cells carry HLA-DR antigens. Clin Immunol Immunopathol (1981) 0.86
Inhibition of the Fc receptor of human lymphoid cells by antisera-recognizing determinants of the hla system. J Exp Med (1976) 0.86
Erythrocytes coated with anti-Rh Ripley react with both the T and the non-T lymphocytes active in antibody-dependent cell-mediated cytotoxicity. Clin Immunol Immunopathol (1980) 0.86
Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm Pharmacol Ther (2007) 0.85
Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy. Vox Sang (2007) 0.85
Reversible agglutination of trypsinised red cells by a gamma-M-globulin synthesized by the human foetus. Scand J Haematol (1966) 0.85
Detection of thrombocyte antibodies by 125I labeled protein A. Tissue Antigens (1978) 0.84
Reversible agglutination of trypsinised red cells by normal human sera: identification of the agglutinating factor as a gamma-M-globulin. Scand J Haematol (1965) 0.84